Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon D Roger

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Clinical Nephrology|November 3, 2017
Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial
Iain C Macdougall, Andreas H Bock, Fernando Carrera, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 22, 2024
Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and cliniciansChanel H Chong, Germaine Wong, Eric H Au, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trialSimon D Roger, Carlo A Gaillard, Andreas H Bock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 studySimon D Roger, Philip T Lavin, Edgar V Lerma, et al.
Plos One|June 9, 2016
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD TrialCarlo A Gaillard, Andreas H Bock, Fernando Carrera, et al.
Current Medical Research and Opinion|June 21, 2008
A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney diseaseSimon D Roger, Michael G Suranyi, Rowan G Walker, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trialSimon D Roger, Lawrence P McMahon, Anthony Clarkson, et al.
Kidney International|February 17, 2012
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insightsIain C Macdougall, Simon D Roger, Angel de Francisco, et al.
JAMA|June 30, 2025
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical TrialManish Saxena, Luke Laffin, Claudio Borghi, et al.
Mayo Clinic Proceedings|November 8, 2020
Clinical Management of HyperkalemiaBiff F Palmer, Juan Jesus Carrero, Deborah J Clegg, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Clinical Nephrology|November 3, 2017
Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial
Iain C Macdougall, Andreas H Bock, Fernando Carrera, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 22, 2024
Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and cliniciansChanel H Chong, Germaine Wong, Eric H Au, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trialSimon D Roger, Carlo A Gaillard, Andreas H Bock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 studySimon D Roger, Philip T Lavin, Edgar V Lerma, et al.
Plos One|June 9, 2016
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD TrialCarlo A Gaillard, Andreas H Bock, Fernando Carrera, et al.
Current Medical Research and Opinion|June 21, 2008
A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney diseaseSimon D Roger, Michael G Suranyi, Rowan G Walker, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trialSimon D Roger, Lawrence P McMahon, Anthony Clarkson, et al.
Kidney International|February 17, 2012
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insightsIain C Macdougall, Simon D Roger, Angel de Francisco, et al.
JAMA|June 30, 2025
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical TrialManish Saxena, Luke Laffin, Claudio Borghi, et al.
Mayo Clinic Proceedings|November 8, 2020
Clinical Management of HyperkalemiaBiff F Palmer, Juan Jesus Carrero, Deborah J Clegg, et al.
Pageof 8